Chargement en cours...
The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae
One potential advantage of live attenuated bacterial vaccines is the ability to stimulate responses to antigens which are only expressed during the course of infection. To determine whether the live attenuated cholera vaccine CVD 103-HgR (Vaxchora) results in antibody responses to the in vivo-induce...
Enregistré dans:
| Publié dans: | Clin Vaccine Immunol |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5216439/ https://ncbi.nlm.nih.gov/pubmed/27847368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00470-16 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|